Advertisement
Screener

RAFAEL HOLDINGS, INC. (RFL) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

RAFAEL HOLDINGS, INC. Capital Expenditures

RAFAEL HOLDINGS, INC. (RFL) reported Capital Expenditures of $5.00 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-06-11

  • RAFAEL HOLDINGS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-04-30 was $0.00.
  • RAFAEL HOLDINGS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-07-31 was -$1.00K, a 112.50% decline year-over-year.
  • RAFAEL HOLDINGS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-04-30 was -$1.00K, a 100.81% decline year-over-year.
  • RAFAEL HOLDINGS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-01-31 was $0.00.
  • RAFAEL HOLDINGS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $4.00K, a 97.20% decline from fiscal 2024.
  • RAFAEL HOLDINGS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $143.00K.
  • RAFAEL HOLDINGS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $2.00K, a 99.03% decline from fiscal 2021.
  • RAFAEL HOLDINGS, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $206.00K, a 61.42% decline from fiscal 2020.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 6 month as first filedPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 9 month as first filedPayments to Acquire Property, Plant, and Equipment 12 month
2026-04-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11
$5.00K
10-Q · filed 2026-06-11
2026-01-31$5.00K
10-Q · filed 2026-03-16
2025-07-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29
-$2.00K
derived: sum of 2 quarters · filed 2026-06-11
-$2.00K
derived: sum of 3 quarters · filed 2026-06-11
$4.00K
10-K · filed 2025-10-29
2025-04-30-$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11
-$1.00K
derived: sum of 2 quarters · filed 2026-06-11
$5.00K
10-Q · filed 2026-06-11
$13.00K
derived: sum of 4 quarters · filed 2026-06-11
2025-01-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16
$6.00K
10-Q · filed 2026-03-16
$14.00K
derived: sum of 3 quarters · filed 2026-03-16
$138.00K
derived: sum of 4 quarters · filed 2026-03-16
2024-10-31$6.00K
10-Q · filed 2025-12-12
$14.00K
derived: sum of 2 quarters · filed 2025-12-12
$138.00K
derived: sum of 3 quarters · filed 2025-12-12
2024-07-31$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29
$132.00K
derived: sum of 2 quarters · filed 2025-10-29
$143.00K
10-K · filed 2025-10-29
2024-04-30$124.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11
$135.00K
10-Q · filed 2025-06-11
2024-01-31$11.00K
10-Q · filed 2025-03-14
2022-07-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30
$0.00
derived: sum of 2 quarters · filed 2023-10-30
-$27.00K
derived: sum of 3 quarters · filed 2023-10-30
$2.00K
10-K · filed 2023-10-30
2022-04-30-$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13
-$28.00K
derived: sum of 2 quarters · filed 2023-06-13
$1.00K
10-Q · filed 2023-06-13
$87.00K
10-Q · filed 2022-06-14
-$30.00K
derived: sum of 4 quarters · filed 2023-06-13
2022-01-31-$27.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-03-14
$2.00K
10-Q · filed 2023-03-14
$62.00K
10-Q · filed 2022-03-17
-$29.00K
derived: sum of 3 quarters · filed 2023-03-14
$3.00K
derived: sum of 4 quarters · filed 2023-03-14
2021-10-31$29.00K
10-Q/A · filed 2022-02-28
-$2.00K
derived: sum of 2 quarters · filed 2022-02-28
$30.00K
derived: sum of 3 quarters · filed 2022-06-14
$90.00K
derived: sum of 4 quarters · filed 2022-06-14
2021-07-31-$31.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18
$1.00K
derived: sum of 2 quarters · filed 2022-06-14
$61.00K
derived: sum of 3 quarters · filed 2022-06-14
$206.00K
10-K · filed 2021-10-18
2021-04-30$32.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14
$92.00K
derived: sum of 2 quarters · filed 2022-06-14
$237.00K
10-Q · filed 2022-06-14
$280.00K
derived: sum of 4 quarters · filed 2022-06-14
2021-01-31$60.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17
$205.00K
10-Q · filed 2022-03-17
$248.00K
derived: sum of 3 quarters · filed 2022-03-17
$283.00K
derived: sum of 4 quarters · filed 2022-03-17
2020-10-31$145.00K
10-Q/A · filed 2022-02-28
$188.00K
derived: sum of 2 quarters · filed 2022-02-28
$223.00K
derived: sum of 3 quarters · filed 2022-02-28
$358.00K
derived: sum of 4 quarters · filed 2022-02-28
2020-07-31$43.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18
$78.00K
derived: sum of 2 quarters · filed 2021-10-18
$213.00K
derived: sum of 3 quarters · filed 2021-10-18
$534.00K
10-K · filed 2021-10-18
2020-04-30$35.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14
$170.00K
derived: sum of 2 quarters · filed 2021-06-14
$491.00K
10-Q · filed 2021-06-14
$526.00K
derived: sum of 4 quarters · filed 2021-06-14
2020-01-31$135.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-03-17
$456.00K
10-Q · filed 2021-03-17
$491.00K
derived: sum of 3 quarters · filed 2021-03-17
$797.00K
derived: sum of 4 quarters · filed 2021-03-17
2019-10-31$321.00K
10-Q · filed 2020-12-15
$356.00K
derived: sum of 2 quarters · filed 2020-12-15
$662.00K
derived: sum of 3 quarters · filed 2020-12-15
$694.00K
derived: sum of 4 quarters · filed 2020-12-15
2019-07-31$35.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29
$341.00K
derived: sum of 2 quarters · filed 2020-10-29
$373.00K
derived: sum of 3 quarters · filed 2020-10-29
$399.00K
10-K · filed 2020-10-29
2019-04-30$306.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09
$338.00K
derived: sum of 2 quarters · filed 2020-06-09
$364.00K
10-Q · filed 2020-06-09
$502.00K
derived: sum of 4 quarters · filed 2020-06-09
2019-01-31$32.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-05
$58.00K
10-Q · filed 2020-03-05
$196.00K
derived: sum of 3 quarters · filed 2020-03-05
$40.00K
derived: sum of 4 quarters · filed 2020-03-05
2018-10-31$26.00K
10-Q · filed 2019-12-09
$164.00K
derived: sum of 2 quarters · filed 2019-12-09
$8.00K
derived: sum of 3 quarters · filed 2019-12-09
$513.00K
derived: sum of 4 quarters · filed 2019-12-09
2018-07-31$138.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04
-$18.00K
derived: sum of 2 quarters · filed 2019-10-04
$487.00K
derived: sum of 3 quarters · filed 2019-10-04
$710.00K
10-K · filed 2019-10-04
2018-04-30-$156.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-05
$349.00K
derived: sum of 2 quarters · filed 2019-06-05
$572.00K
10-Q · filed 2019-06-05
$802.00K
derived: sum of 4 quarters · filed 2019-06-05
2018-01-31$505.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12
$728.00K
10-Q · filed 2019-03-12
$958.00K
derived: sum of 3 quarters · filed 2019-03-12
$1.40M
derived: sum of 4 quarters · filed 2019-03-12
2017-10-31$223.00K
10-Q · filed 2018-12-10
$453.00K
derived: sum of 2 quarters · filed 2018-12-10
$897.00K
derived: sum of 3 quarters · filed 2018-12-10
2017-07-31$230.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15
$674.00K
derived: sum of 2 quarters · filed 2018-10-15
$1.82M
10-K · filed 2018-10-15
2017-04-30$444.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-11
$1.59M
10-Q · filed 2018-06-11
2017-01-31$1.15M
10-Q · filed 2018-03-12
2016-07-31$1.55M
10-K · filed 2018-10-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aditxt, Inc. (ADTX)United States$0.000B
CDT Equity Inc. (CDT)United States$0.000B-0.01
Protagenic Therapeutics, Inc.\new (PTIX)United States$0.001B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B